| Line Item | 2024-09-28 | Y/Y |
|---|---|---|
| Revenue | $1.52B | -8.3% |
| Cost of Revenue | $828.7M | -11.7% |
| Gross Profit | $689.4M | -3.8% |
| R&D Expense | $304.6M | +1.2% |
| SG&A Expense | $142.3M | -15.6% |
| Operating Income | -$48.0M | -133.8% |
| Pre-tax Income | -$27.2M | -717.9% |
| Income Tax | $11.0M | -25.0% |
| Net Income | -$38.1M |
| Line Item | 2024-09-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $169.7M | -22.9% |
| Accounts Receivable | $44.5M | -34.1% |
| Inventory | $231.5M | -33.2% |
| Current Assets | $551.1M | -16.5% |
| Total Assets | $916.3M | -8.6% |
| Current Liabilities | $366.2M | +3.4% |
| Total Liabilities | $487.7M | +0.8% |
| Line Item | 2024-09-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $189.9M | +89.1% |
| Investing Cash Flow | -$105.2M | -109.3% |
| Financing Cash Flow | -$137.3M | -26.4% |
| -271.3% |
| EPS (Basic) | -$0.31 | -287.5% |
| EPS (Diluted) | -$0.31 | -287.5% |
| Stockholders' Equity |
| $428.6M |
| -17.4% |